Cargando…
Response to comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'
In 2016, we reported four substantial observations of APECED/APS1 patients, who are deficient in AIRE, a major regulator of central T cell tolerance (Meyer et al., 2016). Two of those observations have been challenged. Specifically, ‘private’ autoantibody reactivities shared by only a few patients b...
Autores principales: | Hertel, Christina, Fishman, Dmytro, Lorenc, Anna, Ranki, Annamari, Krohn, Kai, Peterson, Pärt, Kisand, Kai, Hayday, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597236/ https://www.ncbi.nlm.nih.gov/pubmed/31244472 http://dx.doi.org/10.7554/eLife.45826 |
Ejemplares similares
-
AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies
por: Meyer, Steffen, et al.
Publicado: (2016) -
Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'
por: Landegren, Nils, et al.
Publicado: (2019) -
Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins
por: Fishman, Dmytro, et al.
Publicado: (2017) -
IL‐6‐specific autoantibodies among APECED and thymoma patients
por: Kärner, Jaanika, et al.
Publicado: (2016) -
Serotonin and tryptophan metabolites, autoantibodies and gut microbiome in APECED
por: Naskali, Emmi, et al.
Publicado: (2019)